from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1181/pks4

LFCtreatmentdescriptionclass of inhibitor

-0.711

Amikacinug/mL Amikacintranslation

-0.095

Cap5-10ug/mL Capreomycintranslation

-1.011

Rox10-50 ug/mL Roxithromycintranslation

-1.057

SM2-5 ug/mL Streptomycintranslation

-1.710

Tet5-10 ug/mL Tetracyclinetranslation

-0.044

Rif0.2-5ug/mL Rifampicintranscription

-0.636

Rifp0.1-0.5ug/mL Rifapentinetranscription

4.157

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.700

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.468

CPZ10-50 ug/mL Chlorpromazinerespiration

0.838

Clofazimine10-13 ug/mL Clofaziminerespiration

0.911

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.827

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.430

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.357

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.867

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.111

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.477

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.603

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.418

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.698

KCN5-20 ug/mL Potassium cyaniderespiration

-0.381

NaN30.2-2 mM Sodium aziderespiration

0.652

Nigericin50 uM Nigericinrespiration

-0.757

TRC10-150 ug/mL Triclosanrespiration

-0.153

TRZ10-25 ug/mL Thioridazinerespiration

0.040

Valinomycin0.5-10 uM Valinomycinrespiration

-0.180

ZnSO42 mM ZnSO4respiration

-1.254

menadione6-10 ug/mL Menadionerespiration

0.131

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.118

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.480

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.203

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.046

NRP_1Non-replicating persistence stage 1dosRassociated

-0.343

Amp0.2mg/mL AmpicillincellWall

-0.481

Cephalexin20-100 ug/mL CephalexincellWall

-0.088

Cerulenin0.32-5 ug/mL CerulenincellWall

1.016

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.263

EMB10-20 ug/mL EthambutolcellWall

-0.124

Eta12-40 ug/mL EthionamidecellWall

-0.334

INH0.2-0.4 ug/mL IsoniazidcellWall

0.674

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.737

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.264

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.364

BZA0.12 mg/mL BenzamidearomaticAmides

-0.799

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.878

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.489

H2O24 mM hydrogen peroxideDNAdamaging

-0.087

Levo10 ug/mL LevofloxacinDNAdamaging

-0.265

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.028

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.648

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.588

UVUV-irradiationDNAdamaging

-1.002

ARP41-4 ug/mL Antitubercular compound ARP4?

0.672

Antimycin12.5-50 ug/mL Antimycin A?

0.007

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.273

PA_110-50 ug/mL Antitubercular compound PA-1?

0.120

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.583

PA8240.2-2 ug/mL PA-824?

-1.995

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.498

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.637

Verapamil50 uM Verapamil?

0.503

mercaptoethanol2 mM 2-Mercaptoethanol?

0.414

methoxatin10-20 ug/mL Methoxatin?